Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Low dose IL-2 for treating autoimmune-related or inflammatory disorders

Low dose IL-2 for treating autoimmune-related or inflammatory disorders

US Patent 12491232 · Granted Dec 9, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of diagnosis of infection by the SARS-CoV-2 virus2025
Virus-like particles which can be used in the treatment of allergies2025
Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and the2025
Immune cells defective for SUV39H12025
Genetically modified T lymphocytes2023
Immune cells defective for SUV39H12023
Use of low dose IL-2 for treating autoimmune-related or inflammatory disorders2023
Use of low dose IL-2 for treating autoimmune-related or inflammatory disorders2023
Use of low dose IL-2 for treating autoimmune-related or inflammatory disorders2023
Use of low dose IL-2 for treating autoimmune-related or inflammatory disorders2023
Use of low dose IL-2 for treating autoimmune-related or inflammatory disorders2023
Use of low dose IL-2 for treating autoimmune-related or inflammatory disorders2023